Cancer Family
Reproductive System Neoplasm
CI-CAN-00000338Explore in graph →
Non-malignant3,042 active trials38 approved drugs197 evidence items
- NCIt
- C3674
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000338Explore in graph →
Clinical trials
13,672 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03955978 | TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer | active not recruiting | Phase 1 | 10 | Washington University School of MedicineOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT05416424 | Life Study: Lifestyle Intervention in Fibroid Elimination | active not recruiting | N/A | 100 | NYU Langone HealthOTHER | 1 | Jan 5, 2026 | clinicaltrials |
| NCT06416696 |
| Toripalimab for High-risk Locally Advanced Cervical Cancer |
| active not recruiting |
| Phase 2 |
| 57 |
| Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER |
| 1 |
| Jan 2, 2026 |
| clinicaltrials |
| NCT01643954 | Retrospective/Prospective Analysis of Surgical Outcomes of Robotic Prostatectomy at The James | active not recruiting | N/A | 1,531 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Dec 31, 2025 | clinicaltrials |
| NCT03602859 | A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer(FIRST) | active not recruiting | Phase 3 | 1,400 | Tesaro, Inc.INDUSTRY | 19 | Dec 31, 2025 | clinicaltrials |
| NCT03955185 | Clinical Trial of Minimally Invasive Surgery Versus Abdominal Surgery in Patients With Early Stage Cervical Cancer(CGOG 002) | active not recruiting | N/A | 2,000 | Huazhong University of Science and TechnologyOTHER | 1 | Dec 31, 2025 | clinicaltrials |
| NCT04141449 | A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation(Potlako+) | active not recruiting | Phase 2 | 874 | Brigham and Women's HospitalOTHER | 1 | Dec 31, 2025 | clinicaltrials |
| NCT05746806 | Trial of Ultrahypofractionated Focal Salvage Radiotherapy for Isolated Prostate Bed Recurrence After Radical Prostatectomy(HypoFocal SRT) | active not recruiting | N/A | 36 | Insel Gruppe AG, University Hospital BernOTHER | 1 | Dec 31, 2025 | clinicaltrials |
| NCT00565851 | Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer | active not recruiting | Phase 3 | 1,052 | National Cancer Institute (NCI)NIH | 3 | Dec 30, 2025 | clinicaltrials |
| NCT02051218 | Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks | active not recruiting | Phase 3 | 1,380 | Swiss Cancer InstituteOTHER | 3 | Dec 30, 2025 | clinicaltrials |
| NCT02285192 | Positron Lymphography Via Intracervical 18F-FDG Injection for Pre-surgical Lymphatic Mapping in Stage IB1 Cervical Cancer and High-grade Endometrial Cancer | active not recruiting | Phase 1 | 42 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 30, 2025 | clinicaltrials |
| NCT03383016 | Diet, Physical Activity and Related Candidate Biomarkers in Relation to Prostate Cancer Risk (BIOCaPPE)(BIOCaPPE) | active not recruiting | — | 2,053 | CHU de Quebec-Universite LavalOTHER | 1 | Dec 30, 2025 | clinicaltrials |
| NCT03809000 | A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery(STEEL) | active not recruiting | Phase 2 | 188 | RTOG Foundation, Inc.OTHER | 2 | Dec 30, 2025 | clinicaltrials |
| NCT05220033 | Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer | active not recruiting | N/A | 30 | Rutgers, The State University of New JerseyOTHER | 1 | Dec 30, 2025 | clinicaltrials |
| NCT07292337 | AcuTENS for Pain Relief During TRUS-Guided Prostate Biopsy | active not recruiting | N/A | 53 | University of MalayaOTHER | 1 | Dec 24, 2025 | clinicaltrials |
| NCT04655365 | Detecting Metastases by PyL PET/CT in Subjects Starting Enzalutamide for Untreated Castration Resistant Prostate Cancer.(PROSTEP-002) | active not recruiting | Phase 2 | 50 | CHU de Quebec-Universite LavalOTHER | 1 | Dec 23, 2025 | clinicaltrials |
| NCT06822491 | Early Magnetic Resonance Imaging Response of the Dominant Intraprostatic Lesion After Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer and Correlation With Prostate Specific Antigen Response(PRODART) | active not recruiting | — | 28 | University of ZurichOTHER | 1 | Dec 23, 2025 | clinicaltrials |
| NCT04670068 | Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial Ovarian | active not recruiting | Phase 1 | 4 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Dec 22, 2025 | clinicaltrials |
| NCT06229366 | [Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer(ACCEL) | active not recruiting | Phase 1 | 142 | Eli Lilly and CompanyINDUSTRY | 1 | Dec 22, 2025 | clinicaltrials |
| NCT02452008 | Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer | active not recruiting | Phase 2 | 60 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT03753334 | Effects of EPA in Men With Biochemical Recurrence or Progression of Prostate Cancer.(RCT-EPAII-BCR) | active not recruiting | Phase 2 | 39 | CHU de Quebec-Universite LavalOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT05407025 | Targeting Inflammation for Endometrial Cancer Prevention | active not recruiting | — | 191 | Mayo ClinicOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT04446117 | Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC(CONTACT-02) | active not recruiting | Phase 3 | 575 | ExelixisINDUSTRY | 27 | Dec 18, 2025 | clinicaltrials |
| NCT00937586 | Prostate Cancer Prospective Cohort | active not recruiting | — | 1,937 | Washington University School of MedicineOTHER | 1 | Dec 17, 2025 | clinicaltrials |
| NCT04126824 | Effect of Addition of Steroids on Duration of Analgesia | active not recruiting | Early Phase 1 | 28 | University of California, Los AngelesOTHER | 1 | Dec 17, 2025 | clinicaltrials |
| NCT06397651 | A Randomised Controlled Trial to Evaluate the Impact of Complement Theory's Live CoActive Exercise Coaching and Personalized Digital Application on Cancer Survivors' Quality of Life | active not recruiting | N/A | 146 | Complement Theory Inc.INDUSTRY | 1 | Dec 17, 2025 | clinicaltrials |
| NCT06682572 | A Study of Avutometinib + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer in Japanese Patients(RAMP201J) | active not recruiting | Phase 2 | 16 | Verastem, Inc.INDUSTRY | 1 | Dec 17, 2025 | clinicaltrials |
| NCT05296512 | Pembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer | active not recruiting | Phase 2 | 30 | Elizabeth K. Lee MDOTHER | 1 | Dec 16, 2025 | clinicaltrials |
| NCT05556772 | Optimizing Screening for Cervical Cancer Among Women Living With HIV in the Dominican Republic | active not recruiting | N/A | 619 | Fred Hutchinson Cancer CenterOTHER | 1 | Dec 16, 2025 | clinicaltrials |
| NCT04025372 | INTREPId (INTermediate Risk Erection PreservatIon Trial) | active not recruiting | Phase 2 | 234 | Brigham and Women's HospitalOTHER | 1 | Dec 15, 2025 | clinicaltrials |
| NCT07283029 | Activity and Cancer Survivorship Exercise Pilot | active not recruiting | N/A | 10 | University of IowaOTHER | 1 | Dec 15, 2025 | clinicaltrials |
| NCT01844986 | Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.(SOLO-1) | active not recruiting | Phase 3 | 450 | AstraZenecaINDUSTRY | 15 | Dec 10, 2025 | clinicaltrials |
| NCT06105918 | Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients With Biochemically Recurrent Prostate Cancer | active not recruiting | Phase 1 | 6 | Emory UniversityOTHER | 1 | Dec 9, 2025 | clinicaltrials |
| NCT07273383 | Self-sampling for HPV Screening(HPVselftest) | active not recruiting | N/A | 1,000 | Université de SherbrookeOTHER | 1 | Dec 9, 2025 | clinicaltrials |
| NCT03511196 | Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer | active not recruiting | Early Phase 1 | 17 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT04319146 | Study of Robot-assisted Radical Prostatectomy Performed on Outpatient in Patients With Localized Prostate Cancer(AMBUPRO) | active not recruiting | N/A | 20 | Centre Hospitalier Universitaire de NiceOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT05189457 | First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer | active not recruiting | Phase 2 | 32 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT05201547 | Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line(DOMENICA) | active not recruiting | Phase 3 | 260 | ARCAGY/ GINECO GROUPOTHER | 10 | Dec 4, 2025 | clinicaltrials |
| NCT07265414 | DRG Mutations in Prostate Cancer: a Guiding Light for Enhanced Screening and Personalised Therapy | active not recruiting | — | 320 | Istituto Clinico HumanitasOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT02869217 | Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors | active not recruiting | Phase 1 | 22 | University Health Network, TorontoOTHER | 1 | Dec 3, 2025 | clinicaltrials |
| NCT07262073 | Comparison of Peak Expiratory Flow Changes After Robot-Assisted Versus Open Radical Prostatectomy | active not recruiting | N/A | 60 | Ankara City Hospital BilkentOTHER | 1 | Dec 3, 2025 | clinicaltrials |
| NCT02341989 | Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer(SWENOTECA-ABC) | active not recruiting | Phase 3 | 348 | St. Olavs HospitalOTHER | 1 | Dec 2, 2025 | clinicaltrials |
| NCT01607008 | MRI for Assessing Prostate Cancer Response(NA_00067284) | active not recruiting | N/A | 38 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Nov 28, 2025 | clinicaltrials |
| NCT03983954 | Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer. | active not recruiting | Phase 1 | 120 | NeoTX Therapeutics Ltd.INDUSTRY | 2 | Nov 28, 2025 | clinicaltrials |
| NCT03143322 | Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases(STEREO-OS) | active not recruiting | N/A | 168 | UNICANCEROTHER | 1 | Nov 26, 2025 | clinicaltrials |
| NCT02023463 | Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer | active not recruiting | Phase 1 | 25 | Thomas Jefferson UniversityOTHER | 1 | Nov 25, 2025 | clinicaltrials |
| NCT05696444 | Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO) | active not recruiting | N/A | 144 | Medtronic - MITGINDUSTRY | 1 | Nov 25, 2025 | clinicaltrials |
| NCT01653925 | Molecular Mechanisms of Dutasteride and Dietary Interventions to Prevent Prostate Cancer and Reduce Its Progression | active not recruiting | N/A | 120 | CHU de Quebec-Universite LavalOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT06572774 | Community Clinic Model to Improve Early Detection of Breast and Cervical Cancers in Kenya(C3Link) | active not recruiting | N/A | 5,400 | ImplenomicsOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT04537156 | Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli) | active not recruiting | Phase 3 | 9,327 | Xiamen UniversityOTHER | 1 | Nov 21, 2025 | clinicaltrials |
Data updated 24 days agoSource updated Jan 6, 2026source: clinicaltrials